T-MAXIMUM Pharmaceutical Inc
1 clinical trials · Sponsor
◉ Watch T-MAXIMUM Pharmaceutical Inc
| Record | Firm | Date |
|---|---|---|
| The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma (NCT07386002) | T-MAXIMUM Pharmaceutical Inc | 2026-06-30 |
Track T-MAXIMUM Pharmaceutical Inc automatically
Every clearance here is in the API, with alerts when new ones post.